NewStem
Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.
About
NewStem is a biopharmaceutical company specializing in Human Pluripotent Stem Cells (HPSCs), with a particular focus on Human Haploid Pluripotent Stem Cells (HHPSCs). These unique cells hold significant potential for advancing regenerative medicine and developing novel therapies for various diseases. Teams look it up for Life Sciences, Biotech, Biopharmaceutical.
Frequently asked
What does NewStem do?
NewStem is a Life Sciences company that offers Services. Teams look it up for Biotech, Biopharmaceutical, MedTech. It is based in Rehovot, Israel and was founded in 2018. Public records show $30M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has NewStem raised?
NewStem has raised a total of $30M in funding. The most recent round on record is Series B.
Where is NewStem headquartered?
NewStem is headquartered in Rehovot, Israel.
When was NewStem founded?
NewStem was founded in 2018.
What industry does NewStem operate in?
NewStem operates in Life Sciences, Biotech, Biopharmaceutical, MedTech, HealthTech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.